Tiziana life sciences plc ("tiziana" or the "company") - tiziana files registration statement on form f-3 with u.s. securities and exchange commission

New york and london, jan. 27, 2021 (globe newswire) -- tiziana life sciences plc (nasdaq: tlsa / lse: tils), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces that it has filed a “universal” shelf registration statement on form f-3 (file no. 333-252441) (the "registration statement") with the u.s. securities and exchange commission ("sec") in relation to up to us$250,000,000 in market value of its securities.
TLSA Ratings Summary
TLSA Quant Ranking